Abstract
Interleukin-1 receptor antagonist (IL-1Ra) is unique among primary inflammatory cytokines because its molecular activity is entirely passive and negative (1–3). Because it is a pure antagonist of the inflammatory cytokine IL-1, a deficiency of IL-1Ra not only reveals processes for which IL-1Ra is essential but highlights pathologies that involve overactivity of IL-1. IL-1Ra deficiency is not associated with developmental pathology. To some extent IL-1Ra knockouts resemble transgenics that overexpress inflammatory cytokines (see, for example, refs. 4 and 5) in that both types of mice develop site-specific inflammatory diseases because of localized excessive inflammatory responses. The remarkable feature of the inflammatory diseases that we observe in IL-1Ra-deficient mice is that they are tissue-specific without any intention on the part of the investigators to target the hyperactivity of IL-1. The disturbed balance of activity of the IL-1 system, even though it is part of the innate immune system, appears to feed into the activity of the adaptive immune response, creating autoimmune conditions. Investigating the mechanism for this specificity may well yield important insights into the nature of chronic inflammatory diseases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Eisenberg, S. P., Evans, R. J., Arend, W. P., et al. (1990) Primary structure and functional expression from complementary-DNA of a human interleukin-1 receptor antagonist. Nature 343, 341–346.
Hannum, C. H., Wilcox, C. J., Arend, W. P., et al. (1990) cDNA cloning of an intracellular form of the human interleukin-1 receptor antagonist associated with epithelium. Nature 343, 336–340.
Dripps, D. J., Verderber, E., Ng, R. K., Thompson, R. C., and Eisenberg, S. P. (1991) Interleukin-1 receptor antagonist binds to the type-II interleukin-1 receptor on B-cells and neutrophils. J. Biol. Chem. 266, 20311–20315.
Kassiotis, G. and Kollias, G. (2001) TNF and receptors in organ-specific autoimmune disease: multi-layered functioning mirrored in animal models. J. Clin. Invest. 107, 1507–1508.
Niki, Y., Yamada, H., Seki, S., et al. (2001) Macrophage-and neutrophil-dominant arthritis in human IL-1 alpha transgenic mice. J. Clin. Invest. 107, 1127–1135.
Nicklin, M. J. H., Barton, J. L., Nguyen, M., FitzGerald, M. G., Duff, G. W., and Kornman, K. (2002) A sequence-based map of the nine genes of the human interleukin-1 cluster. Genomics 79, 718–725.
Taylor, S. L., Renshaw, B. R., Garka, K. E., Smith, D. E., and Sims, J. E. (2002) Genomic organization of the interleukin-1 locus. Genomics 79, 726–733.
Graves, B. J., Hatada, M. H., Hendrickson, W. A., Miller, J. K., Madison, V. S., and Satow, Y. (1990) Structure of interleukin 1-alpha at 2.7-a resolution. Biochemistry 29, 2679–2684.
Priestle, J. P., Schar, H. P., and Grutter, M. G. (1989) Crystallographic refinement of interleukin1-beta at 2.0 A resolution. Proc. Natl. Acad. Sci. USA 86, 9667–9671.
Vigers, G. P. K., Caffes, P., Evans, R. J., Thompson, R. C., Eisenberg, S. P., and Brandhuber, B. J. (1994) X-ray structure of interleukin-1 receptor antagonist at 2.0-Angstrom resolution. J. Biol. Chem. 269, 12874–12879.
Sims, J. E., Nicklin, M. J. H., Bazan, J. F., et al. (2001) A new nomenclature for IL-1-family genes. Trends Immunol. 22, 536–537.
Dunn, E., Sims, J. E., Nicklin, M. J. H., and O’Neill, L. A. J. (2001) Annotating genes with potential roles in the immune system: six new members of the IL-1 family. Trends Immunol. 22, 533–536.
Barton, J. L., Herbst, R., Bosisio, D., Higgins, L., and Nicklin, M. J. H. (2000) A tissue specific IL-1 receptor antagonist homolog from the IL-1 cluster lacks IL-1, IL-Ira, IL-18 and IL-18 antagonist activities. Eur. J. Immunol. 30, 3299–3308.
Lin, H. S., Ho, A. S., Haley-Vicente, D., et al. (2001) Cloning and characterization of IL-1HY2, a novel interleukin-1 family member. J Biol. Chem. 276, 20597–20602.
Silver, A. R. J., Masson, W. K., George, A. M., Adam, J., and Cox, R. (1990) The IL-1-alpha-gene and IL-1-beta-gene are closely linked (less-than 70 kb) on mouse chromosome-2. Somat. Cell Mol. Genet. 16, 549–556.
Zahedi, K., Seldin, M. F., Rits, M., Ezekowitz, R. A. B., and Whitehead, A. S. (1991) Mouse IL-1 receptor antagonist protein—molecular characterization, gene-mapping, and expression of messenger-RNA in vitro and in vivo. J. Immunol. 146, 4228–4233.
Horai, R., Asano, M., Sudo, K., et al. (1998) Production of mice deficient in genes for interleukin (IL)-1 alpha, IL-1 beta, IL-1 alpha/beta, and IL-1 receptor antagonist shows that IL-1 beta is crucial in turpentine-induced fever development and glucocorticoid secretion. J. Exp. Med. 187, 1463–1475.
Zahedi, K. A., Uhlar, C. M., Rits, M., Prada, A. E., and Whitehead, A. S. (1994) The mouse interleukin-1 receptor antagonist protein—gene structure and regulation in-vitro. Cytokine 6, 1–9.
Gabay, C., Porter, B., Fantuzzi, G., and Arend, W. P. (1997) Mouse IL-1 receptor antagonist isoforms: complementary DNA cloning and protein expression of intracellular isoform and tissue distribution of secreted and intracellular IL-1 receptor antagonist in vivo. J. Immunol. 159, 5905–5913.
Irikura, V. M., Lagraoui, M., and Hirsh, D. (2002) The epistatic relationships between IL-1, IL-1 receptor antagonist, and the type I IL-1 receptor. J. Immunol. 169, 393–398.
Malyak, M., Guthridge, J. M., Hance, K. R., Dower, S. K., Freed, J. H., and Arend, W. P. (1998a) Characterization of a low molecular weight isoform of IL-1 receptor antagonist. J Immunol. 161, 1997–2003.
Haskill, S., Martin, G., Van Le, L., et al. (1991) cDNA cloning of an intracellular form of the human interleukin-1 receptor antagonist assocviated with epithelium. Proc. Natl. Acad. Sci. USA 88, 3681–3685.
Muzio, M., Polentarutti, N., Facchetti, F., et al. (1999) Characterization of type II intracellular IL-1 receptor antagonist (IL-lra3): a depot IL-lra. Eur. J. Immunol. 29, 781–788.
Seckinger, P., Williamson, K., Balavoine, J. F., et al. (1987) A urine inhibitor of interleukin-1 activity affects both interleukin 1 a and 1f3 but not tumor necrosis factor a. J. Immunol. 139, 1541–1545.
Seckinger, P., Lowenthal, J. W., Williamson, K., Dayer, J. M., and MacDonald, H. R. (1987) A urine inhibitor of interleukin 1 activity that blocks ligand binding. J. Immunol. 139, 1546–1549.
Greenfeder, S. A., Nunes, P., Kwee, L., Labow, M., Chizzonite, R. A., and Ju, G. (1995) Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex. J. Biol. Chem. 270, 13757–13765.
Korherr, C., Hofmeister, R., Wesche, H., and Falk, W. (1997) A critical role for interleukin-1 receptor accessory protein in interleukin-1 signaling. Eur. J. Immunol. 27, 262–267.
Schreuder, H., Tardif, C., Trump-Kallmeyer, S., et al. A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist. Nature 386, 194–200.
Vigers, G. P. A., Anderson, L. J., Caffes, P., and Brandhuber, B. J. (1997) Crystal structure of the type-I interleukin-1 receptor complexed with interleukin-1 beta. Nature 386, 190–194.
Colotta, F., Re, F., Muzio, M., et al. (1993) Interleukin-1 type II receptor-a decoy target for IL-1 that is regulated by IL-4. Science 261, 472–475.
Malinowsky, D., Lundkvist, J., Laye, S., and Bartfai, T. (1998) Interleukin-1 receptor accessory protein interacts with the type II interleukin-1 receptor. FEBS Lett. 429, 299–302.
McMahan, C. J., Slack, J. L., Mosley, B., et al. (1991) A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell-types. EMBO J. 10, 2821–2832.
Watson, J. M., Lofquist, A. K., Rinehart, C. A., et al. (1995) The intracellular IL-1 receptor antagonist alters IL-1-inducible gene-expression without blocking exogenous signaling by IL-113. J. Immunol. 155, 4467–4475.
Janson, R. W., Hance, K. R., and Arend, W. P. (1991) Production of IL-1-receptor antagonist by human in vitro-derived macrophages-effects of lipopolysaccharide and granulocyte-macrophage colony-stimulating factor. J. Immunol. 147, 4218–4223.
Lore, K., Sonnerborg, A., Spetz, A. L., Andersson, U., and Andersson, J. (1998) Immunocytochemical detection of cytokines and chemokines in Langerhans cells and in vitro derived dendritic cells. J. Immunol. Methods 214, 97–111.
McColl, S. R., Paquin, R., Menard, C., and Beaulieu, A. D. (1992) Human neutrophils produce high-levels of the interleukin-1 receptor antagonist in response to granulocyte macrophage colony-stimulating factor and tumor necrosis factor a. J. Exp. Med. 179, 593–598.
Malyak, M., Smith, M. F., Abel, A. A., and Arend, W. P. (1994) Peripheral-blood neutrophil production of interleukin-1 receptor antagonist and interleukin-1(3. J. Clin. Immunol. 14, 20–30.
Dewberry, R. M., Holden, H., Crossman, D. C., and Francis, S. E. (2000) Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 20, 2394–2400.
Hagaman, D. D., Okayama, Y., D’Ambrosio, C., Prussin, C., Gilfillan, A. M., and Metcalfe, D. D. (2001) Secretion of interleukin-1 receptor antagonist from human mast cells after immunoglobulin E-mediated activation and after segmental antigen challenge. Am. J. Respir. Cell Mol. Biol. 25, 685–691.
Chan, L. S., Hammerberg, C., Kang, K., Sabb, P., Tavakkol, A., and Cooper, K. D. (1992) Human dermal fibroblast interleukin-1 receptor antagonist (IL-1Ra) and interleukin- 1-beta(IL-113) messenger-RNA and protein are co-stimulated by phorbol ester—implication for a homeostatic mechanism. J. Invest. Derm. 99, 315–322.
Silvera, M. R. and Phipps, R. P. (1995) Synthesis of interleukin-1 receptor antagonist by Thy-1(+) and Thy-1(-) murine lung fibroblast subsets. J. Interferon Cytokine Res. 15, 63–70.
Steinkasserer, A., Estaller, C., Weiss, E. H., and Sim, R. B. (1992) Human interleukin-1 receptor antagonist is expressed in liver. FEBS Lett. 310, 60–62.
Gabay, C., Porter, B., Guenette, D., Billir, B., and Arend, W. P. (1999) Interleukin-4 (IL-4) and IL-13 enhance the effect of IL-1 beta on production of IL-1 receptor antagonist by human primary hepatocytes and hepatoma HepG2 cells: differential effect on C-reactive protein production. Blood 93, 1299–1307.
Cerretti, D. P., Kozlosky, C. J., Mosley, B., et al. (1992) Molecular-cloning of the interleukin-1-beta converting enzyme. Science 256, 97–100.
MacKenzie, A., Wilson, H. L., Kiss-Toth, E., Dower, S. K., North, R. A., and Surprenant, A. (2001) Rapid secretion of interleukin-1 beta by microvesicle shedding. Immunity 15, 825–835.
Arend, W. P. and Leung, D. Y. M. (1994) IgG induction of IL-1 receptor antagonist production by human monocytes. Immunol. Rev. 139, 71–78.
Arend, W. P., Smith, M. F. Jr., Janson, R., and Joslin, F. G. (1991) IL-1 receptor antagonist and IL-1-beta production in human monocytes are regulated differently. J. Immunol. 147, 1530–1536.
Fenton, M. J., Buras, J. A., and Donnelly, R. P. (1992) IL-4 reciprocally regulates IL-1 and IL-1 receptor antagonist expression in human monocytes. J. Immunol. 149, 1283–1288.
Vannier, E., Miller, L. C., and Dinarello, C. (1992) Co-ordinated anti-inflammatory effects of interleukin-4. Interleukin-4 suppresses interleukin-1 production but up-regiulates gene-expression and synthesis of interleukin-1 receptor antagonist. Proc. Natl. Acad. Sci. USA 89, 4076–4080.
Beasley, D., McGuiggin, M. E., and Dinarello, C. A. (1995) Human vascular smooth-muscle cells produce an intracellular form of interleukin-1 receptor antagonist. Am. J. Physiol. 38, C961 - C968.
Bigler, C. F., Norris, D. A., Weston, W. L., and Arend, W. P. (1992) Interleukin-1 receptor antagonist production by human keratinocytes. J. Invest. Dermatol. 98, 38–44.
Levine, S. J., Wu, T., and Shelhamer, J. H. (1997) Extracellular release of the type I intracellular IL-1 receptor antagonist from human airway epithelial cells—differential effects of IL-4, IL-13, IFN-gamma, and corticosteroids. J. Immunol. 158, 5949–5957.
Merot, Y., Didienean, L., Dayer, J. M., Fournier, C., Canaux, P., and Saurat, J. H. (1987) Immunoreactive interleukin-1 (IL-1) alpha and beta in normal human-skin. J. Invest. Dermatol. 89, 327.
Hirsch, E., Irikura, V. M., Paul, S. M., and Hirsh, D. (1996) Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice. Proc. Natl. Acad. Sci. USA 93, 11008–11013.
Nicklin, M. J. H., Hughes, D. E., Barton, J. L., Ure, J. M., and Duff, G. W. (2000) Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene. J. Exp. Med. 191, 303–311.
Hentze, M. W. and Kulozik, A. E. (1999) A perfect message: RNA surveillance and nonsense-mediated decay. Cell 96, 307–310.
Ma, Y. H., Thornton, S., Boivin, G. P., Hirsh, D., Hirsch, R., and Hirsch, E. (1998) Altered susceptibility to collagen-induced arthritis in transgenic mice with aberrant expression of interleukin-1 receptor antagonist. Arthritis Rheum. 41, 1798–1805.
Devlin, C. M., Kuriakose, G., Hirsch, E., and Tabas, I. (2002) Genetic alterations of IL-1 receptor antagonist in mice affect plasma cholesterol level and foam cell lesion size. Proc. Natl. Acad. Sci. USA 99, 6281–6285.
Nagy, A., Rossant, J., Nagy, R., Abramow-Newerly, W., and Roder, J. C. (1990) Derivation of completely cell culture-derived mice from early-passage embryonic stem-cells. Proc. Natl. Acad. Sci USA 90, 8424–8428.
Horai, R., Saijo, S., Tanika, M., et al. (2000) Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J. Exp. Med. 191, 313–320.
Josephs, M. D., Solorzano, C. C., Taylor, M., et al. (2000) Modulation of the acute phase response by altered expression of the IL-1 type 1 receptor or IL-lra. Am. J. Physiol. 278, R824 - R830.
Wallenius, V., Wallenius, K., Ahren, B., et al. (2002) Interleukin-6-deficient mice develop mature onset obesity. Nature Med. 8, 75–79.
Glaccum, M. B., Stocking, K. L., Charrier, K., et al. (1997) Phenotypic and functional characterization of mice that lack the type I receptor for IL-1. J. Immunol. 159, 3364–3371.
Dinarello, C. A., Ikejima, T., Warner, S. J. C., et al. (1987) Interleukin-1 induces interleukin-1.1. Induction of circulating interleukin-1 in rabbits in vivo and in human mononuclear cells in vitro. J. Immunol. 139, 1902–1910.
Warner, S. J. C., Auger, K. R., and Libby, P. (1987) Human interleukin-1 induces interleukin-1 gene-expression in human vascular smooth-muscle cells. J. Exp. Med. 165, 1316–1331.
Leon, L. R., Conn, C. A., Glaccum, M., and Kluger, M. J. (1996) IL-1 type I receptor mediates acute phase response to turpentine, but not lipopolysaccharide, in mice. Am. J. Physiol. 271, R1668 - R1675.
Ross, R. (1995) Cell biology of atherosclerosis. Annu. Rev. Physiol. 57, 791–804.
Francis, S. E., Camp, N. J., Dewberry, R. M., et al. (1999) Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease. Circulation 99, 861–866.
Garcia-Cardena, G., Comander, J., Anderson, K. R., Blackman, B. R., and Gimbrone, M. A. (2001) Biomechanical activation of vascular endothelium as a determinant of its functional phenotype. Proc. Natl. Acad. Sci. USA 98, 4478–4485.
Iwakura, Y. (2002) Roles of IL-1 in the development of rheumatoid arthritis: consideration from mouse models. Cytokine Growth Factor Rev. 13, 341–355.
Simon, A. K., Seipelt, E., and Seiper, J. (1994) Divergent T cell cytokine patterns in inflammatory arthritis. Proc. Natl. Acad. Sci USA 91, 8562–8566.
Chatelain, R., Varkila, K., and Cofman, R. L. (1992) IL-4 induces a TH2 response in Leishmania major-infected mice. J. Immunol. 148, 1182–1187.
Vollmer, S., Menssen, A., and Prinz, J. C. (1994) T lymphocytes derived from skin lesions of patients with psoriasis vulgaris express a novel cytokine pattern that is distinct from that of T helper type 1 and type 2 cells. Eur. J. Immunol. 24, 3277–3282.
Schlaak, J. F., Buslau, M., Jochum, W., et al. (1994) T-cells involved in psoriasis vulgaris belong to the TH1 subset. J. Invest. Dermatol. 102, 145–149.
Uyemura, K., Yamamura, M., Fivenson, D. F., Modlin, R. L., and Nickoloff, B. J. (1993) The cytokine network in lesional and lesion-free psoriatic skin is characterized by T-helper type-1 cell-mediated response. J. Invest. Dermatol. 101, 701–705.
Sallusto, F., Cella, M., Danieli, C., and Lanzavecchia, A. (1995) Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatability complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182, 389–400.
Roake, J. A., Rao, A. S., Morris, P. J., Larsen, C. P., Hankins, D. F., and Austyn, J. M. (1995) Dendritic cell loss from nonlymphoid tissue after systematic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1. J. Exp. Med. 181, 2237–2247.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Nicklin, M.J.H., Shepherd, J. (2003). IL-1 Receptor Antagonist-Deficient Mice. In: Fantuzzi, G. (eds) Cytokine Knockouts. Contemporary Immunology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-405-4_7
Download citation
DOI: https://doi.org/10.1007/978-1-59259-405-4_7
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-415-9
Online ISBN: 978-1-59259-405-4
eBook Packages: Springer Book Archive